# BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

> clinical trial · VERIFIED · 2026-06-15

Status: RECRUITING · Sponsor: SillaJen, Inc. · Condition: Advanced Solid Tumor

- Company: SillaJen, Inc.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05768932

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.